CD81
CD81 antigen
Also known as: CD81_HUMAN, TAPA-1, TAPA1, TSPAN28
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60033
- Gene
- CD81
- Ensembl
- ENSG00000110651
- Chromosome
- 11
- Canonical length
- 236 aa
- Protein class
- CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. Most of these members are cell-surface proteins that are characterized by the presence of four hydrophobic domains. The proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth and motility. This encoded protein is a cell surface glycoprotein that is known to complex with integrins. This protein appears to promote muscle cell fusion and support myotube maintenance. Also it may be involved in signal transduction. This gene is localized in the tumor-suppressor gene region and thus it is a candidate gene for malignancies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Canonical amino-acid sequenceUniProt
236 residues, UniProt reviewed canonical sequence.
>P60033|CD81
1 MGVEGCTKCI KYLLFVFNFV FWLAGGVILG VALWLRHDPQ TTNLLYLELG DKPAPNTFYV
61 GIYILIAVGA VMMFVGFLGC YGAIQESQCL LGTFFTCLVI LFACEVAAGI WGFVNKDQIA
121 KDVKQFYDQA LQQAVVDDDA NNAKAVVKTF HETLDCCGSS TLTALTTSVL KNNLCPSGSN
181 IISNLFKEDC HQKIDDLFSG KLYLIGIAAI VVAVIMIFEM ILSMVLCCGI RNSSVYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD81 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 1,494 nTPM
Expression across tissuesHPA
Tissue
- seminal vesicle: 1,494 nTPM
- endometrium: 1,244 nTPM
- liver: 1,133 nTPM
- blood vessel: 1,003 nTPM
- cervix: 939 nTPM
- colon: 928 nTPM
Single-cell type
- breast lactating cells: 1,124 nCPM
- smooth muscle cells: 1,085 nCPM
- fallopian secretory cells: 865 nCPM
- epididymal principal cells: 853 nCPM
- fallopian tube ciliated cells: 817 nCPM
- endometrial stromal cells: 765 nCPM
Immune cell
- memory B-cell: 149 nTPM
- naive B-cell: 138 nTPM
- MAIT T-cell: 34 nTPM
- memory CD8 T-cell: 33 nTPM
- eosinophil: 23 nTPM
- gdT-cell: 21 nTPM
Brain region
- white matter: 886 nTPM
- spinal cord: 844 nTPM
- medulla oblongata: 765 nTPM
- thalamus: 762 nTPM
- midbrain: 721 nTPM
- hypothalamus: 672 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CD81.
Disease | AllUniProt
Conditions CD81 is implicated in, by any mechanism.
- Immunodeficiency, common variable, 6 (CVID6) MIM:613496
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 327 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency, common variable, 6
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.38
- gnomAD pLI
- 0.92
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to low-density lipoprotein particle stimulus
- humoral immune response mediated by circulating immunoglobulin
- immunological synapse formation
- myoblast fusion involved in skeletal muscle regeneration
- osteoclast fusion
- positive regulation of B cell proliferation
- positive regulation of B cell receptor signaling pathway
- positive regulation of CD4-positive, alpha-beta T cell proliferation
- positive regulation of inflammatory response to antigenic stimulus
- positive regulation of MAPK cascade
- positive regulation of protein catabolic process in the vacuole
- positive regulation of protein exit from endoplasmic reticulum
- positive regulation of receptor clustering
- positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell
- positive regulation of T cell receptor signaling pathway
- positive regulation of T-helper 2 cell cytokine production
- positive regulation of transcription by RNA polymerase II
- protein localization to lysosome
- protein localization to plasma membrane
- receptor internalization
- regulation of macrophage migration
- regulation of protein stability
- CD4-positive, alpha-beta T cell costimulation
- macrophage fusion
- positive regulation of adaptive immune memory response
Molecular functions
- cholesterol binding
- integrin binding
- MHC class II protein binding
- MHC class II protein complex binding
- transferrin receptor binding
- virus receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CD81 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD81 as an antibody target. Whether an autoantibody or antibody against CD81 could matter depends on whether native CD81 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD81 is annotated at the cell surface, where native CD81 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD81 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...